MNX1 and pancreatic adenocarcinoma: While its fold changes between normal and tumour samples were lower than MNX1 and MNX1-AS1, its expression levels were particularly high in gastro-intestinal tract and testicular tumours, with the highest negative fold change in pancreatic adenocarcinoma.